UBS Group
GEN

UBS Group’s Genesis Healthcare, Inc. GEN Stock Holding History

UBS Group’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-950,000
Closed -$1.12M – 8402
2018
Q4 		$1.12M Buy
+950,000
New +$1.41M ﹤0.01% 3569

Other funds holding GEN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

UBS Group's GEN Position: Q1 2021 in Review

UBS Group sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 16,813 shares — an estimated $8K sold.

UBS Group first reported a position in GEN in Q2 2015 and held it in 18 quarters. The position peaked at $178K in Q4 2019. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • UBS Group reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • UBS Group sold 16,813 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $8K.
  • UBS Group first reported a position in Genesis Healthcare, Inc. in Q2 2015 and held it in 18 quarters.
  • UBS Group's Genesis Healthcare, Inc. position peaked at $178K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.